343 related articles for article (PubMed ID: 23324973)
1. Screening and treating Chlamydia trachomatis genital infection to prevent pelvic inflammatory disease: interpretation of findings from randomized controlled trials.
Gottlieb SL; Xu F; Brunham RC
Sex Transm Dis; 2013 Feb; 40(2):97-102. PubMed ID: 23324973
[TBL] [Abstract][Full Text] [Related]
2. Early screening for Chlamydia trachomatis in young women for primary prevention of pelvic inflammatory disease (i-Predict): study protocol for a randomised controlled trial.
Tamarelle J; Thiébaut ACM; Sabin B; Bébéar C; Judlin P; Fauconnier A; Rahib D; Méaude-Roufai L; Ravel J; Morré SA; de Barbeyrac B; Delarocque-Astagneau E;
Trials; 2017 Nov; 18(1):534. PubMed ID: 29132441
[TBL] [Abstract][Full Text] [Related]
3. Direct and indirect effects of screening for Chlamydia trachomatis on the prevention of pelvic inflammatory disease: a mathematical modeling study.
Herzog SA; Heijne JC; Scott P; Althaus CL; Low N
Epidemiology; 2013 Nov; 24(6):854-62. PubMed ID: 24076992
[TBL] [Abstract][Full Text] [Related]
4. [Chlamydia trachomatis infection in women and the use of oral contraceptives].
van Voorst Vader PC; Lier JG; Posma AL; Schröder FP; Schirm J; Kauer FM
Ned Tijdschr Geneeskd; 1991 Feb; 135(8):323-7. PubMed ID: 2008220
[TBL] [Abstract][Full Text] [Related]
5. The program cost and cost-effectiveness of screening men for Chlamydia to prevent pelvic inflammatory disease in women.
Gift TL; Gaydos CA; Kent CK; Marrazzo JM; Rietmeijer CA; Schillinger JA; Dunne EF
Sex Transm Dis; 2008 Nov; 35(11 Suppl):S66-75. PubMed ID: 18830137
[TBL] [Abstract][Full Text] [Related]
6. Screening and treatment to prevent sequelae in women with Chlamydia trachomatis genital infection: how much do we know?
Gottlieb SL; Berman SM; Low N
J Infect Dis; 2010 Jun; 201 Suppl 2():S156-67. PubMed ID: 20470051
[TBL] [Abstract][Full Text] [Related]
7. Acute pelvic inflammatory disease.
Eschenbach DA
Urol Clin North Am; 1984 Feb; 11(1):65-81. PubMed ID: 6369707
[TBL] [Abstract][Full Text] [Related]
8. Equipoise redux: do we need more randomized controlled trials of Chlamydia screening?
Chow JM
Sex Transm Dis; 2013 Feb; 40(2):103-4. PubMed ID: 23321989
[No Abstract] [Full Text] [Related]
9. [Opportunistic screening for genital infections with Chlamydia trachomatis in sexually active population of Amsterdam. II. Cost-effectiveness analysis of screening women].
Ruitenberg EN
Ned Tijdschr Geneeskd; 1999 May; 143(19):1012. PubMed ID: 10368724
[No Abstract] [Full Text] [Related]
10. Epidemiology of Chlamydia trachomatis infection in women and the cost-effectiveness of screening.
Land JA; Van Bergen JE; Morré SA; Postma MJ
Hum Reprod Update; 2010; 16(2):189-204. PubMed ID: 19828674
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness analysis of screening adolescent males for Chlamydia on admission to detention.
Blake DR; Gaydos CA; Quinn TC
Sex Transm Dis; 2004 Feb; 31(2):85-95. PubMed ID: 14743071
[TBL] [Abstract][Full Text] [Related]
12. Preventing infective sequelae of abortion.
Penney GC
Hum Reprod; 1997 Nov; 12(11 Suppl):107-12. PubMed ID: 9433966
[TBL] [Abstract][Full Text] [Related]
13. Chlamydia trachomatis infections: screening, diagnosis, and management.
Mishori R; McClaskey EL; WinklerPrins VJ
Am Fam Physician; 2012 Dec; 86(12):1127-32. PubMed ID: 23316985
[TBL] [Abstract][Full Text] [Related]
14. The Chlamydia cascade: enhanced STD prevention strategies for adolescents.
Chiaradonna C
J Pediatr Adolesc Gynecol; 2008 Oct; 21(5):233-41. PubMed ID: 18794017
[TBL] [Abstract][Full Text] [Related]
15. Overestimation of complication rates in evaluations of Chlamydia trachomatis screening programmes--implications for cost-effectiveness analyses.
van Valkengoed IG; Morré SA; van den Brule AJ; Meijer CJ; Bouter LM; Boeke AJ
Int J Epidemiol; 2004 Apr; 33(2):416-25. PubMed ID: 15082651
[TBL] [Abstract][Full Text] [Related]
16. Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial.
Oakeshott P; Kerry S; Aghaizu A; Atherton H; Hay S; Taylor-Robinson D; Simms I; Hay P
BMJ; 2010 Apr; 340():c1642. PubMed ID: 20378636
[TBL] [Abstract][Full Text] [Related]
17. Chlamydia trachomatis in pelvic inflammatory disease.
Shrikhande SN; Joshi SG; Zodpey SP; Saoji AM
Indian J Pathol Microbiol; 1995 Apr; 38(2):181-4. PubMed ID: 8919106
[TBL] [Abstract][Full Text] [Related]
18. Screening for chlamydial infection.
Nelson HD; Helfand M
Am J Prev Med; 2001 Apr; 20(3 Suppl):95-107. PubMed ID: 11306238
[TBL] [Abstract][Full Text] [Related]
19. Chlamydia trachomatis genital infections--United States, 1995.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1997 Mar; 46(9):193-8. PubMed ID: 9072679
[TBL] [Abstract][Full Text] [Related]
20. Chlamydia screening and pelvic inflammatory disease: Insights from exploratory time-series analyses.
Owusu-Edusei K; Bohm MK; Chesson HW; Kent CK
Am J Prev Med; 2010 Jun; 38(6):652-7. PubMed ID: 20494242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
